{"id":51119,"date":"2026-06-22T23:11:37","date_gmt":"2026-06-22T21:11:37","guid":{"rendered":"https:\/\/prizrenpost.com\/tr\/bilim-insanlari-uyariyor-eklem-agrilari-icin-kullanilan-takviye-demans-riskini-artirabilir\/"},"modified":"2026-06-22T23:11:37","modified_gmt":"2026-06-22T21:11:37","slug":"bilim-insanlari-uyariyor-eklem-agrilari-icin-kullanilan-takviye-demans-riskini-artirabilir","status":"publish","type":"post","link":"https:\/\/prizrenpost.com\/tr\/bilim-insanlari-uyariyor-eklem-agrilari-icin-kullanilan-takviye-demans-riskini-artirabilir\/","title":{"rendered":"Bilim insanlar\u0131 uyar\u0131yor: Eklem a\u011fr\u0131lar\u0131 i\u00e7in kullan\u0131lan takviye demans riskini art\u0131rabilir!"},"content":{"rendered":"

<\/p>\n

Yeni bir \u00e7al\u0131\u015fma, eklem a\u011fr\u0131s\u0131n\u0131 hafifletmek i\u00e7in yayg\u0131n olarak kullan\u0131lan re\u00e7etesiz bir takviye olan glukozaminin uzun s\u00fcreli kullan\u0131m\u0131yla ilgili endi\u015feleri art\u0131rd\u0131.<\/p>\n

Reuters’a g\u00f6re bunun d\u00fczenli kullan\u0131m\u0131, daha y\u00fcksek demans geli\u015fme riskiyle ba\u011flant\u0131l\u0131 olabilir.<\/p>\n

Ara\u015ft\u0131rmac\u0131lar, 2012 ile 2024 y\u0131llar\u0131 aras\u0131nda farkl\u0131 d\u00fczeylerde demans hastas\u0131 olan yakla\u015f\u0131k 60.000 hastadan toplanan t\u0131bbi verileri analiz etti. bili\u015fsel bozukluk.<\/p>\n

Sonu\u00e7lar, d\u00fczenli olarak glukozamin kullanan ki\u015filerde demans geli\u015fme olas\u0131l\u0131\u011f\u0131n\u0131n, kullanmayanlara g\u00f6re %25 daha fazla oldu\u011funu g\u00f6sterdi.<\/p>\n

\u00c7al\u0131\u015fma ayr\u0131ca halihaz\u0131rda demans hastas\u0131 olan hastalarda glukozamin kullan\u0131m\u0131n\u0131n g\u00f6zlem s\u00fcresi boyunca %25 oran\u0131nda artan \u00f6l\u00fcm riskiyle ili\u015fkili oldu\u011funu da buldu.
\nBu etki hafif bili\u015fsel bozuklu\u011fu olan ki\u015filerde g\u00f6zlenmedi, bu da takviyenin etkisinin hastal\u0131\u011f\u0131n ileri evrelerinde daha b\u00fcy\u00fck olabilece\u011fini d\u00fc\u015f\u00fcnd\u00fcr\u00fcyor. Olas\u0131 mekanizmay\u0131 anlamak i\u00e7in bilim insanlar\u0131 hayvanlar \u00fczerinde de deneyler yapt\u0131.<\/p>\n

Glukosaminin, \u015feker molek\u00fcllerinin beyindeki proteinlere anormal \u015fekilde ba\u011flanarak \u00f6nemli n\u00f6rolojik fonksiyonlar\u0131 engelledi\u011fi, hiperglikozilasyon olarak bilinen bir s\u00fcreci k\u00f6t\u00fcle\u015ftirebildi\u011fini buldular.<\/p>\n

\u00c7al\u0131\u015fman\u0131n ortak yazar\u0131 Matt Gentry, verilerin \u00e7ok k\u0131\u015fk\u0131rt\u0131c\u0131 oldu\u011funu ancak hen\u00fcz do\u011frudan bir neden-sonu\u00e7 ili\u015fkisini kan\u0131tlamad\u0131\u011f\u0131n\u0131 vurgulad\u0131.<\/p>\n

Ona g\u00f6re sonu\u00e7lar \u00f6nemli bir klinik durumu ortaya \u00e7\u0131kar\u0131yor. daha fazla ara\u015ft\u0131rmay\u0131 hak eden bir soru.<\/p>\n

“Do\u011fa Metabolizmas\u0131” dergisindeki \u00e7al\u0131\u015fmayla birlikte yay\u0131nlanan bir yorum, glikozilasyon s\u00fcrecinin demansla m\u00fccadelede yeni bir terap\u00f6tik hedef olabilece\u011fini \u00f6ne s\u00fcr\u00fcyor.<\/p>\n

Ancak uzmanlar, hastalara glukozamin kullan\u0131m\u0131nda de\u011fi\u015fiklik \u00f6nermeden \u00f6nce daha fazla \u00e7al\u0131\u015fmaya ihtiya\u00e7 oldu\u011funu vurguluyor.<\/p>\n

\n

Kaynak: prizrenpost<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Yeni bir \u00e7al\u0131\u015fma, eklem a\u011fr\u0131s\u0131n\u0131 hafifletmek i\u00e7in yayg\u0131n olarak kullan\u0131lan re\u00e7etesiz bir takviye olan glukozaminin uzun s\u00fcreli kullan\u0131m\u0131yla ilgili endi\u015feleri art\u0131rd\u0131. Reuters’a g\u00f6re bunun d\u00fczenli kullan\u0131m\u0131, daha y\u00fcksek demans geli\u015fme riskiyle ba\u011flant\u0131l\u0131 olabilir. Ara\u015ft\u0131rmac\u0131lar, 2012 ile 2024 y\u0131llar\u0131 aras\u0131nda farkl\u0131 d\u00fczeylerde demans hastas\u0131 olan yakla\u015f\u0131k 60.000 hastadan toplanan t\u0131bbi verileri analiz etti. bili\u015fsel bozukluk. Sonu\u00e7lar, […]<\/p>\n","protected":false},"author":1,"featured_media":51120,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-51119","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"views":5,"_links":{"self":[{"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/posts\/51119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/comments?post=51119"}],"version-history":[{"count":1,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/posts\/51119\/revisions"}],"predecessor-version":[{"id":51121,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/posts\/51119\/revisions\/51121"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/media\/51120"}],"wp:attachment":[{"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/media?parent=51119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/categories?post=51119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prizrenpost.com\/tr\/wp-json\/wp\/v2\/tags?post=51119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}